Medications for Iron

4 results

  • Deferoxamine (deferoxamine mesylate)

    (DEFEROXAMINE MESYLATE)
    Fresenius Kabi USA, LLC
    Usage: Deferoxamine Mesylate for Injection is indicated for treating acute iron intoxication and chronic iron overload in patients with chronic anemia. However, it is not recommended for primary hemochromatosis, where phlebotomy is preferred for iron removal.

  • Deferoxamine mesylate (deferoxamine mesylate)

    (Deferoxamine mesylate)
    Apotex Corp.
    Usage: Deferoxamine mesylate for injection is indicated for treating acute iron intoxication and chronic iron overload due to transfusions in chronic anemia patients. It is not recommended for primary hemochromatosis, where phlebotomy is preferred.

  • Desferal (deferoxamine mesylate)

    (deferoxamine mesylate)
    Novartis Pharmaceuticals Corporation
    Usage: DESFERAL is indicated for treating acute iron intoxication and for managing chronic iron overload in patients with chronic anemia. It is not suitable for primary hemochromatosis, where phlebotomy is preferred.

  • Ferriprox (deferiprone)

    (deferiprone)
    Chiesi USA, Inc.
    Usage: FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for use in myelodysplastic syndrome or Diamond Blackfan anemia.